Similar articles

• Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.

  Rosenau J, Tillmann HL, Bahr MJ, Trautwein C, Boeker KH, Nashan B, Klempnauer J, Manns MP. Rosenau J, et al. Transplant Proc. 2001 Nov-Dec;33(7-8):3637-8. doi: 10.1016/s0041-1345(01)02564-7. Transplant Proc. 2001. PMID: 11750544 No abstract available.
• Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.

  Ben-Ari Z, Mor E, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R. Ben-Ari Z, et al. Transplant Proc. 2003 Mar;35(2):609-11. doi: 10.1016/s0041-1345(03)00008-3. Transplant Proc. 2003. PMID: 12644066 No abstract available.
• An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

  Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P. Han SH, et al. Liver Transpl. 2000 Nov;6(6):741-8. doi: 10.1053/jlts.2000.18702. Liver Transpl. 2000. PMID: 11084061
• Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there.

  Samuel D. Samuel D. J Hepatol. 2001 Jun;34(6):943-5. doi: 10.1016/s0168-8278(01)00102-7. J Hepatol. 2001. PMID: 11451182 Review. No abstract available.
• [Treatment of hepatitis B].

  Telegdy L. Telegdy L. Orv Hetil. 2004 Nov 7;145(45):2293-6. Orv Hetil. 2004. PMID: 15573894 Review. Hungarian.